Your browser doesn't support javascript.
loading
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer.
Jandu, Harkeran K; Veal, Colin D; Fachal, Laura; Luccarini, Craig; Aguado-Barrera, Miguel E; Altabas, Manuel; Azria, David; Baten, Adinda; Bourgier, Celine; Bultijnck, Renée; Colciago, Riccardo R; Farcy-Jacquet, Marie-Pierre; Chang-Claude, Jenny; Choudhury, Ananya; Dunning, Alison; Elliott, Rebecca M; Green, Sheryl; Gutiérrez-Enríquez, Sara; Herskind, Carsten; Lambrecht, Maarten; Monten, Christel; Rancati, Tiziana; Reyes, Victoria; Rosenstein, Barry S; De Ruysscher, Dirk; Carmen De Santis, Maria; Seibold, Petra; Sperk, Elena; Veldwijk, Marlon; Paul Symonds, R; Stobart, Hilary; Taboada-Valladares, Begoña; Vega, Ana; Veldeman, Liv; Webb, Adam J; Weltens, Caroline; West, Catharine M; Rattay, Tim; Talbot, Christopher J.
Afiliación
  • Jandu HK; Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom.
  • Veal CD; Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom.
  • Fachal L; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.
  • Luccarini C; Centre for Cancer Genetic Epidemiology, Strangeways Research Laboratory, University of Cambridge, Cambridge, United Kingdom.
  • Aguado-Barrera ME; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain; Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain.
  • Altabas M; Department of Radiation Oncology, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Azria D; Institut de Recherche en Cancérologie de Montpellier, University Federation of Radiation Oncology of Mediterranean Occitanie, Université de Montpellier, INSERM U1194 IRCM, Montpellier, France.
  • Baten A; Radiation Oncology, UZ Leuven, Leuven, Belgium.
  • Bourgier C; Institut de Recherche en Cancérologie de Montpellier, University Federation of Radiation Oncology of Mediterranean Occitanie, Université de Montpellier, INSERM U1194 IRCM, Montpellier, France.
  • Bultijnck R; Department of Human Structure and Repair, Ghent University, Ghent, Belgium.
  • Colciago RR; Unit of Radiation Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Farcy-Jacquet MP; Institut de Cancérologie du Gard, University Federation of Radiation Oncology of Mediterranean Occitanie, CHU Carémeau, Nîmes, France.
  • Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Cancer Epidemiology Group, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Choudhury A; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, UK.
  • Dunning A; Centre for Cancer Genetic Epidemiology, Strangeways Research Laboratory, University of Cambridge, Cambridge, United Kingdom.
  • Elliott RM; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, UK.
  • Green S; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Gutiérrez-Enríquez S; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Herskind C; Department of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Lambrecht M; Radiation Oncology, UZ Leuven, Leuven, Belgium.
  • Monten C; Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium.
  • Rancati T; Unit of Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Reyes V; Department of Radiation Oncology, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Rosenstein BS; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • De Ruysscher D; MAASTRO Clinic, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands.
  • Carmen De Santis M; Unit of Radiation Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Seibold P; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sperk E; Department of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Veldwijk M; Department of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Paul Symonds R; Leicester Cancer Research Centre, University of Leicester, Leicester, United Kingdom.
  • Stobart H; Patient Advocate, Independent Cancer Patients' Voice, UK.
  • Taboada-Valladares B; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
  • Vega A; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain; Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain.
  • Veldeman L; Department of Human Structure and Repair, Ghent University, Ghent, Belgium; Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium.
  • Webb AJ; Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom.
  • Weltens C; Radiation Oncology, UZ Leuven, Leuven, Belgium.
  • West CM; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, UK.
  • Rattay T; Leicester Cancer Research Centre, University of Leicester, Leicester, United Kingdom. Electronic address: tr104@le.ac.uk.
  • Talbot CJ; Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom.
Radiother Oncol ; 187: 109806, 2023 10.
Article en En | MEDLINE | ID: mdl-37437607
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Traumatismos por Radiación / Neoplasias de la Mama Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Radiother Oncol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Irlanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Traumatismos por Radiación / Neoplasias de la Mama Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Radiother Oncol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Irlanda